Systemic endocrine instigation of indolent tumor growth requires osteopontin.
about
Tumor self-seeding by circulating cancer cellsExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionSOCE and cancer: Recent progress and new perspectivesTargeting Breast Cancer MetastasisTumor heterogeneity and its implication for drug deliveryPerspectives on reprograming cancer-associated dendritic cells for anti-tumor therapiesThe microenvironment in breast cancer progression: biology and implications for treatmentTargeting tumor-stromal interactions in bone metastasisSurgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceA combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasisOsteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.Microenvironmental regulation of metastasisAccelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisMacrophage diversity enhances tumor progression and metastasisTumor metastasis: molecular insights and evolving paradigmsPhylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding siteBone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger.Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical DataIntracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53.Breast tumour stroma is a prognostic indicator and target for therapy.Tumor heterogeneity: causes and consequencesYAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes.Molecular mechanisms of bone metastasis and associated muscle weakness.Homologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106Oncoprotein metastasis and its suppression revisited.Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.Components of the hematopoietic compartments in tumor stroma and tumor-bearing miceObligate progression precedes lung adenocarcinoma dissemination.Interstitial guidance of cancer invasion.Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors.Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cellsThe role of the microenvironment in mammary gland development and cancer.Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse modelsCombination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
P2860
Q24658224-F135E2E2-2A26-4E79-BC8B-6D09DE77AF1FQ26775189-E1423236-189C-4B93-8C20-D9BE232EF3E4Q26781966-E41F5BD9-5ADE-4DBC-BC6A-D797A6E6E561Q26783925-8F70DAF2-CB73-4849-ACA4-E1ADDE811935Q26829096-F6A46F34-C30F-489E-9FD1-54486532A6D7Q26830839-F75DAD4D-F24B-4EA7-BC83-EE8CADF40AD2Q26851314-66490205-E340-439B-AF53-E217555A2070Q27024561-2C6FB1CB-A00D-449E-8967-1EA4AB42E7FBQ27345519-B487BCB6-D3C2-4E16-B372-18B4CE9C1D97Q28276647-576F0A3E-8790-4CB9-9D18-A69FFE7ADC11Q28509843-14AD55D8-CF1C-4329-8B35-63BDD602002EQ29547660-3FDD1C61-7133-4A49-8C4D-F477162C6009Q29614537-BA236898-BA6B-440B-AF3D-67065D713062Q29615847-DD0A697A-77E2-4910-83A5-AADF59D7CCA4Q29615908-C3FDA4C4-B6A7-454F-8443-C9246BFA6BE2Q30403025-596415AA-BAF9-4D13-8926-F4D7BF57A7A5Q30487764-CEDFBE76-59FD-419E-ACE0-42F1F79B3F74Q30491509-7A37CAE4-7A65-4FE0-B5D0-664D993582ABQ31112729-1ED36F5F-A248-4B34-87E0-EBBEA1034AA1Q33496631-8A519376-130F-4956-BBF0-4067D955D83CQ33555526-6C45976B-C5E1-4B12-9617-C95CE9D41845Q33624298-0F6C361E-C5F0-4A96-891D-1E5392098BB9Q33644875-A9197606-7C67-44AA-9269-7DAF99F329DCQ33694661-99D92C6D-EE3F-4E3C-A4C8-31E269F379EBQ33758508-43CB3BC1-1AE9-44CA-912E-BF06C1E4D1FCQ33778236-A6C63A70-17A8-4447-B482-F7A5639993CAQ33793748-ED99FAB6-4396-46FC-8528-03D25813A8D6Q33854515-C1D7BF92-91F3-478A-AAD0-AD16E7DB7917Q33862702-EDC71782-0F70-484F-9CE6-460FEBA87037Q33875584-1A07E493-5A8E-4947-B403-51C4A7EDAC36Q34029050-96C50B14-E544-4C43-BB33-F7273B1C429EQ34152009-FBD9819C-4D84-478B-AB3B-D603ACDEB5DAQ34173692-0821A4CA-C157-4F2F-82B8-C89F8D1CB894Q34241137-3FA51BD3-8CD0-41D2-A25E-E8AD94554156Q34241451-E74F3613-7B2B-4A11-BB0B-74D6AA7B2D32Q34250074-F547AA1F-3EE7-4A28-A1CD-F41C69A5F1A6Q34406041-9AAF6BA7-E58A-4B26-BAF2-BAEDEB56BD67Q34441622-AA503349-285E-4F5B-AB48-BA5D5790A49CQ34501850-14B8B754-3225-4095-9954-D9A8C8ECEDB5Q34519881-5AE4FFB9-DD25-4721-B195-B3A0D77AC856
P2860
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@ast
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@en
type
label
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@ast
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@en
prefLabel
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@ast
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@en
P2093
P2860
P1433
P1476
Systemic endocrine instigation of indolent tumor growth requires osteopontin.
@en
P2093
Ann M Gifford
Ashley L Greiner
Bonnie L Hylander
Elizabeth A Repasky
Lyndsay N Harris
Matthew P Saelzler
Sandra S McAllister
Stephen P Kelleher
Tan A Ince
P2860
P304
P356
10.1016/J.CELL.2008.04.045
P407
P577
2008-06-01T00:00:00Z